Analysed JAZZ PHARMACEUTICALS PLC (JAZZ:NASDAQ) News Sources
Jazz Pharmaceuticals Provides Update on Zepzelca® (lurbinectedin) Phase 3 LAGOON Trial in Second-Line Small Cell Lung Cancer
12-06-2026
yahoo.com
Pharmaceuticals Stocks Q1 Recap: Benchmarking Jazz Pharmaceuticals (NASDAQ:JAZZ)
15-06-2026
yahoo.com
Jazz Pharmaceuticals Delivers Extensive Late-Breaking Data at SLEEP 2026, Demonstrating Real-World Impact of Xywav® (calcium, magnesium, potassium, and sodium oxybates) on Patient Outcomes Across Narcolepsy and Idiopathic Hypersomnia
16-06-2026
yahoo.com
Jazz Pharmaceuticals and AbCellera Announce Collaboration to Discover Next-Generation T-cell Engaging Multispecific Antibodies
17-06-2026
yahoo.com
Jazz Pharmaceuticals and AbCellera Partner on Antibody Programs for Solid Tumors
17-06-2026
advfn.com
What is the current price of JAZZ PHARMACEUTICALS PLC (JAZZ:NASDAQ)?
The current price of JAZZ PHARMACEUTICALS PLC (JAZZ:NASDAQ) is $227.49.
JAZZ PHARMACEUTICALS PLC (JAZZ:NASDAQ) absolute price change since previous trading day?
The absolute price change of JAZZ PHARMACEUTICALS PLC (JAZZ:NASDAQ) since the previous trading day is $0.61.
JAZZ PHARMACEUTICALS PLC (JAZZ:NASDAQ) percentage price change since previous trading day?
The percentage price change of JAZZ PHARMACEUTICALS PLC (JAZZ:NASDAQ) since the previous trading day is 0.2689%.
What is the most recent average sentiment score for JAZZ PHARMACEUTICALS PLC (JAZZ:NASDAQ)?
The most recent average sentiment score for JAZZ PHARMACEUTICALS PLC (JAZZ:NASDAQ) is 81 out of 100.
What is the most recent average sentiment for JAZZ PHARMACEUTICALS PLC (JAZZ:NASDAQ)?
The most recent sentiment for JAZZ PHARMACEUTICALS PLC (JAZZ:NASDAQ) is .
SEC-8K** Filing Available For JAZZ PHARMACEUTICALS PLC (JAZZ:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.